MoneyWorks4Me

USFDA conducting inspection at Sun Pharma’s Mohali facility

12 Sep 2018 Evaluate

The United States Food and Drug Administration (USFDA) is conducting an inspection at Sun Pharmaceutical Industries’ Mohali facility in state of Punjab. The inspection by the USFDA started on September 10, 2018 and is ongoing.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.15
Dr. Reddys Labs. 1198.20
Cipla 1330.00
Lupin 2006.70
Zydus Lifesciences 1151.00
View more..